What If London Loses One Of Its Top Companies?
Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.
The AstraZeneca facility in Gaithersburg, Maryland, US.
Photographer: Graeme Sloan/BloombergThis article is for subscribers only.
Welcome to the award-winning Money Distilled newsletter. I’m John Stepek. Every week day I look at the biggest stories in markets and economics, and explain what it all means for your money.
Pharmaceutical giant AstraZeneca Plc is currently the third-biggest company in the UK’s headline FTSE 100 index by market capitalisation, if you want to be really pedantic. At this morning’s prices, it accounts for around 7.28% of the entire FTSE 100, just behind banking group HSBC Holdings Plc. on 7.31%. Oil major Shell Plc leads on 7.35%.